Organization | Pusan National University

Pusan National University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Pusan Korea, Republic of (1946)

Organization Overview

First Clinical Trial

2006

NCT01037842

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Busan National University Hospital | Busan National University Yangsan Hospital | Department of Urology, Pusan National University Hospital | Dept. of Anesthesia, Pusan National University, School of Medicine | Hyun Jun Park | Integrated Research Institute for Natural Ingredients and Functional Foods | Korean Medicine Hospital of Pusan National University | Korean Medicine Hospital, Pusan National University | National Clinical Research Center for Korean Medicine Pusan National University Korean Medicine Hospital | Pusan National University | Pusan National University College of Medicine | Pusan National University Hospital | Pusan National University Hospital 179 Gudeok-Ro Seo-Gu, Busan, 602-739, Korea | Pusan National University Hospital, Korea | Pusan National University Korean Medicine Hospital | Pusan National University School of Medicine & Pusan National University Hospital | Pusan National University Yangsan Hospital | Pusan National University Yangsan Hospital of Korea | Pusan National University Yansan Hospital | Pusan National Universtiy Hospital | Pusan National Universtiy Hospital of Korea | Pusan National Universty Hospital | Pusan National Univ. Hospital | Pusan University Hospital | Sang Yeoup Lee | Yangsan Pusan National University Hospital

Active Ingredients

Drugs in Phase 4 Trials (54)

5,7-dihydroxy-3',4',6-trimethoxyflavone (3 trials)

adefovir dipivoxil (hepsera) (2 trials)

aflibercept (zaltrap) (2 trials)

betamethasone (celestone) (1 trial)

bevacizumab (avastin) (1 trial)

clopidogrel (plavix) (2 trials)

conjugated linoleic acid (1 trial)

daclatasvir (daklinza) (1 trial)

dexmedetomidine (precedex) (1 trial)

dihydroxydibutylether group (1 trial)

entecavir (baraclude) (6 trials)

everolimus (zortress) (1 trial)

fenugreek seed (1 trial)

ginseng (3 trials)

glimepiride (amaryl) (1 trial)

glycopyrronium (robinul) (1 trial)

hifenac (1 trial)

imatinib (gleevec) (3 trials)

interferon alpha-2b (Intron-A) (2 trials)

kbmsi-2 (1 trial)

lamivudine (epivir) (6 trials)

lespedeza cuneata (1 trial)

lobeglitazone (1 trial)

misoprostol (cytotec) (1 trial)

motilitone (2 trials)

mycophenolate (myfortic) (1 trial)

naftopil (1 trial)

neostigmine (bloxiverz) (1 trial)

olmesartan (benicar) (2 trials)

pantoline (2 trials)

pioglitazone (actos) (2 trials)

polygoni multiflori radix complex extract (1 trial)

propofol (diprivan) (2 trials)

quinapril (accupril) (1 trial)

ramosetron (2 trials)

ranibizumab (lucentis) (3 trials)

rebamipide (1 trial)

ribavirin (virazole) (1 trial)

ropivacaine (naropin) (1 trial)

sevoflurane (ultane) (1 trial)

silodosin (rapaflo) (1 trial)

sirolimus (rapamune) (2 trials)

sitagliptin (januvia) (1 trial)

sugammadex (bridion) (1 trial)

sunvepra (1 trial)

tacrolimus (prograf) (2 trials)

telbivudine (tyzeka) (2 trials)

telmisartan (micardis) (1 trial)

tenofovir (viread) (3 trials)

thioctic acid (1 trial)

ticagrelor (brilinta) (2 trials)

valsartan (diovan) (1 trial)

vildagliptin (1 trial)

Drugs in Phase 3 Trials (40)

acetylsalicylic acid (aspirin) (1 trial)

amlodipine (norvasc) (3 trials)

asiasarum sieboldi f. maekawa (1 trial)

autologous culture chondrocytes (Carticel) (1 trial)

avanafil (stendra) (2 trials)

bismuth (1 trial)

candesartan (atacand) (1 trial)

capecitabine (xeloda) (1 trial)

cinnamomum cassia (1 trial)

ckd-352 (1 trial)

cyclosporine (sandimmune) (1 trial)

da-3002 (3 trials)

diquafosol (1 trial)

ephedra (1 trial)

ethambutol (myambutol) (1 trial)

fimasartan (kanarb) (3 trials)

furestem (1 trial)

gemcitabine (gemzar) (1 trial)

glycyrrhiza (1 trial)

gv 1001 (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

isoniazid (nydrazid) (1 trial)

lansoprazole (prevacid) (1 trial)

lipiodol (1 trial)

losartan (cozaar) (1 trial)

metronidazole (flagyl) (1 trial)

mitiglinide (1 trial)

nicorandil (1 trial)

paeonia lactiflora (1 trial)

pyrazinamide (Aldinamide) (2 trials)

rhizoma pinelliae (1 trial)

rifampin (1 trial)

schisandra chinensis (3 trials)

somatropin (protropin) (2 trials)

tetracycline (tetrex) (1 trial)

tirofiban (aggrastat) (1 trial)

udenafil (3 trials)

ulmus macrocarpa extract (1 trial)

ursolic acid (1 trial)

Zingiber officinale (1 trial)

Drugs in Phase 2 Trials (30)

allogeneic plx-pad cells (1 trial)

bendamustine (treanda) (1 trial)

busulfan (myleran) (1 trial)

cisplatin (platinol) (2 trials)

cyclophosphamide (cytoxan) (1 trial)

da-8031 (1 trial)

da-9801 (1 trial)

doxorubicin (Doxil) (2 trials)

ebvint cell (1 trial)

etoposide (vepesid) (1 trial)

filgrastim (neupogen) (1 trial)

ibritumomab tiuxetan (zevalin) (1 trial)

idarubicin (idamycin) (1 trial)

irinotecan (Camptosar) (1 trial)

ketamine (ketalar) (1 trial)

levofloxacin (levaquin) (1 trial)

linezolid (zyvox) (1 trial)

methotrexate (1 trial)

neu2000kwl (1 trial)

opc-67683 (1 trial)

oxaliplatin (eloxatin) (1 trial)

pemetrexed (alimta) (1 trial)

pexastimogene devacirepvec (1 trial)

prednisone (meticorten) (1 trial)

rituximab (rituxan) (1 trial)

sp-8203 (1 trial)

tadalafil (cialis) (1 trial)

vinblastine (velban) (1 trial)

vincristine (oncovin) (1 trial)

yhd1023 (1 trial)

Drugs in Phase 1 Trials (2)

da-3030 (1 trial)

vgx-6150 (1 trial)

Drugs in Other Trials (27)

aureobasidium pullulans var. pullutans (1 trial)

bacillus coagulans (1 trial)

bifidobacterium breve (1 trial)

bombyx mori fiber (1 trial)

clarithromycin (biaxin) (1 trial)

Collagen Tripeptide (1 trial)

dapoxetine (priligy) (1 trial)

dasatinib (sprycel) (1 trial)

eungyosan (1 trial)

fermented oyster extract (1 trial)

fermented protaetia brevitarsis seulensis (1 trial)

fermented prunus mume vinegar (1 trial)

glucose (1 trial)

green tea (1 trial)

hydrolyzed oyster extract (1 trial)

ishige okamurae (1 trial)

krill oil (1 trial)

lindera obtusiloba extract (1 trial)

melilotus officinalis (1 trial)

midazolam (versed) (1 trial)

pumpkin seed oil (1 trial)

remifentanil (ultiva) (1 trial)

rivastigmine (exelon) (1 trial)

samsoeum (1 trial)

sargassum horneri (1 trial)

skate (1 trial)

solifenacin (vesicare) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Coronary Syndrome (Phase 3)

Adenocarcinoma (Phase 2)

Cancer Pain (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Cerebral Infarction (Phase 2)

Choroidal Neovascularization (Phase 4)

Cognitive Dysfunction (Phase 4)

Coronary Artery Disease (Phase 4)

Delirium (Phase 4)

Dermatitis (Phase 4)

Dermatitis, Seborrheic (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Neuropathies (Phase 4)

Dry Eye Syndromes (Phase 3)

Dwarfism (Phase 3)

Dyspepsia (Phase 4)

Edema (Phase 4)

Emergence Delirium (Phase 4)

Erectile Dysfunction (Phase 4)

Essential Hypertension (Phase 3)

Eye Diseases (Phase 3)

Familial Primary Pulmonary Hypertension (Phase 3)

Gastritis (Phase 4)

Glomerulonephritis (Phase 3)

Glomerulonephritis, IGA (Phase 4)

Gonadal Dysgenesis (Phase 3)

Heart Arrest (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hyperplasia (Phase 4)

Hypertension (Phase 3)

Hypogonadism (Phase 4)

Infarction (Phase 4)

Infertility (Phase 4)

Infertility, Male (Phase 4)

Intermittent Claudication (Phase 2)

Ischemia (Phase 2)

Keratoconjunctivitis Sicca (Phase 3)

Kidney Diseases (Phase 4)

Leukemia (Phase 4)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 4)

Leukemia, Myeloid (Phase 4)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Liver Diseases (Phase 4)

Lower Urinary Tract Symptoms (Phase 4)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Lymphoma, T-Cell (Phase 2)

Macular Degeneration (Phase 4)

Macular Edema (Phase 4)

Myelodysplastic Syndromes (Phase 2)

Myocardial Infarction (Phase 4)

Neuralgia (Phase 2)

Out-of-Hospital Cardiac Arrest (Phase 2)

Pancreatic Neoplasms (Phase 3)

Peripheral Arterial Disease (Phase 2)

Prediabetic State (Phase 4)

Premature Birth (Phase 2)

Premature Ejaculation (Phase 2)

Prostatic Hyperplasia (Phase 4)

Recurrence (Phase 4)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Sarcopenia (Phase 3)

ST Elevation Myocardial Infarction (Phase 4)

Stomach Neoplasms (Phase 3)

Stroke (Phase 2)

Syndrome (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Multidrug-Resistant (Phase 2)

Tuberculosis, Pulmonary (Phase 3)

Turner Syndrome (Phase 3)

Vaccinia (Phase 2)

Vascular Diseases (Phase 4)

Ventricular Remodeling (Phase 4)

Wounds and Injuries (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 119
# of Trial APIs: 153